Subcutaneous mosunetuzumab replaced the IV infusion for patients with R/R LBCL; 57.5% had mostly mild injection-site ...

A mouse study found 100% survival at 277 days after a single subcutaneous live influenza injection, with no detectable ...

The FDA has approved olanzapine extended-release injectable suspension (Weltruza; Teva Pharmaceuticals), a once-monthly ...

A schizophrenia drug previously taken daily is now available as a once-monthly subcutaneous (SC) injection. On October 9, the ...

The FDA has approved Weltruza, the first once-monthly, subcutaneous, long-acting injectable form of olanzapine for adults ...

The US Food and Drug Administration (FDA) has approved atezolizumab and hyaluronidase-tqjs (Tecentriq Hybreza, Genentech, Inc.) as a subcutaneous injection in adults, covering all approved indications ...

Please provide your email address to receive an email when new articles are posted on . Leqembi Iqlik is the first approved in-home anti-amyloid injectable for early Alzheimer’s disease. Patients ...

The FDA has approved Enspryng (satralizumab, Genentech) for thyroid eye disease (TED), making the drug the first subcutaneous ...

Subcutaneous immunotherapy for cancer can cause many of the same side effects as intravenous (IV) immunotherapy because it involves the same medications. Injection site reactions are a common but ...

Key points of this discussion]Syringes and needles have evolved to deliver insulin 'subcutaneously, reliably, and in a way ...

A person receives subcutaneous immunotherapy as an injection under the skin. This treatment method has shown similar effectiveness to intravenous (IV) infusions that healthcare professionals often use ...